New combo aims to slow aggressive lung cancer in the liver
Disease control
Recruiting now
This study tests whether adding the drug bevacizumab to standard chemo-immunotherapy can help people with advanced small cell lung cancer that has spread to the liver. About 39 participants will receive the combination for four cycles, then continue on two maintenance drugs for u…
Phase: PHASE2 • Sponsor: Kamya Sankar • Aim: Disease control
Last updated May 17, 2026 04:34 UTC